{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:01:29Z","timestamp":1705363289460},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.dld.2004.05.015","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T17:23:58Z","timestamp":1100280238000},"page":"10-22","source":"Crossref","is-referenced-by-count":17,"title":["Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years\u2019 continuous treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"K.D.","family":"Bardhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Polak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Romanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schaefer-Preuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Luehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"McCaldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2004.05.015_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1572-0241.2001.03185.x","article-title":"Pantoprazole therapy in the long-term management of severe acid peptic disease","volume":"96","author":"Bardhan","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2004.05.015_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.1991.tb01472.x","article-title":"The Sydney system: epidemiology and natural history of chronic gastritis","volume":"6","author":"Sipponen","year":"1991","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2004.05.015_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1046\/j.1365-2036.2001.01105.x","article-title":"Long-term lansoprazole treatment for gastroesophageal reflux disease: clinical efficacy and influence on gastric mucosa","volume":"15","author":"Geboes","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2036.2003.01446.x","article-title":"A randomised, double-blind trial of the efficacy and safety of 10mg or 20mg rabeprazole compared with 20mg omeprazole in the maintenance of gastroesophageal reflux disease over five years","volume":"17","author":"Thjodleifsson","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000048863","article-title":"Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa","volume":"64","author":"Lamberts","year":"2001","journal-title":"Digestion"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2004.05.015_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2036.1993.tb00589.x","article-title":"An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high dose ranitidine treatment","volume":"7","author":"Brunner","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2004.05.015_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2036.1994.tb00259.x","article-title":"Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment","volume":"8","author":"Brunner","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2004.05.015_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000200921","article-title":"Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment","volume":"51","author":"Solcia","year":"1992","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2004.05.015_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-121-3-199408010-00001","article-title":"Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety","volume":"121","author":"Klinkenberg-Knol","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2004.05.015_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2036.1998.00349.x","article-title":"Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection","volume":"12","author":"Schenk","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/gast.1999.0029900319","article-title":"Lack of effect of acid suppression therapy on gastric atrophy","volume":"117","author":"Lundell","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.1997.v112.pm9041231","article-title":"Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia","volume":"112","author":"Eissele","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2036.2000.00768.x","article-title":"Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors","volume":"14","author":"Laine","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib15","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2004.05.015_bib16","first-page":"A14(67)","article-title":"Helicobacter eradication for the prevention of atrophic gastritis during omeprazole therapy: a prospective randomised trial","volume":"120","author":"Kuipers","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib17","first-page":"A285","article-title":"Intragastric pH and omeprazole (OME): role of Helicobacter pylori (HP) and HP-associated gastritis","volume":"110","author":"Verdu","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","article-title":"Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer","volume":"110","author":"Labenz","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.37.6.743","article-title":"Effect of curing Helicobacter pylori infection on intra-gastric pH during treatment with omeprazole","volume":"37","author":"Verdu","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.dld.2004.05.015_bib20","first-page":"A64","article-title":"H. pylori related increase in omeprazole (OME) effect is associated with ammonia production","volume":"110","author":"Bercik","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1572-0241.1999.982_e.x","article-title":"Helicobacter pylori, GERD and efficacy of omeprazole therapy for gastroesophageal reflux disease","volume":"94","author":"Shenk","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2004.05.015_bib22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1365-2036.1997.00246.x","article-title":"Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole","volume":"11","author":"Hattlebakk","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib23","unstructured":"Carlsson R. Does the presence of Helicobacter pylori infection influence the response to acid inhibition therapy in patients with gastroesophageal reflux disease? Ph.D. thesis, Gastroesophageal reflux disease. A study of pathophysiology, clinical diagnosis and management. University of Gothenburg, Gothenburg, Sweden."},{"key":"10.1016\/j.dld.2004.05.015_bib24","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2001.29332","article-title":"Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease","volume":"121","author":"Moayyedi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib25","doi-asserted-by":"crossref","first-page":"A235","DOI":"10.1016\/S0016-5085(98)80952-9","article-title":"A six year assessment of tinidazole, metronidazole, clarithromycin, tetracycline and amoxycillin resistance in Helicobacter pylori clinical isolates: a rising tide of antibiotic resistance?","volume":"114","author":"Morton","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2004.05.015_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1440-1746.2002.02735.x","article-title":"Update on the management of Helicobacter pylori infection, including drug-resistant organisms","volume":"17","author":"Goh","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl","key":"10.1016\/j.dld.2004.05.015_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2036.2002.0160s1024.x","article-title":"Review article: treatment of Helicobacter pylori infection and factors influencing eradication","volume":"16","author":"Qasim","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1054\/drup.2001.0203","article-title":"Resistance of Helicobacter pylori to antibiotics and its impact on treatment options","volume":"4","author":"Megraud","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.dld.2004.05.015_bib29","doi-asserted-by":"crossref","first-page":"134S","DOI":"10.1046\/j.1365-2672.2001.01362.x","article-title":"Antibiotic resistance of Helicobacter pylori","volume":"30","author":"Kusters","year":"2001","journal-title":"Symp Ser Soc Appl Microbiol"},{"key":"10.1016\/j.dld.2004.05.015_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1155\/2000\/218256","article-title":"Helicobacter pylori antibiotic resistance: trends over time","volume":"14","author":"Lahaie","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2004.05.015_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1155\/2000\/562159","article-title":"Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada","volume":"14","author":"Fallone","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2004.05.015_bib32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1155\/2000\/601256","article-title":"Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group","volume":"14","author":"Hunt","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2004.05.015_bib33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/1381612003399077","article-title":"Antibiotic-resistant H. pylori infection and its treatment","volume":"6","author":"Graham","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.dld.2004.05.015_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2036.2000.00675.x","article-title":"Review article: nitroimidazole resistance in Helicobacter pylori","volume":"14","author":"Van der Wouden","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2004.05.015_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/bega.1999.0062","article-title":"The problem of Helicobacter pylori-negative idiopathic ulcer disease","volume":"14","author":"Peura","year":"2000","journal-title":"Bailliere's Clin Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865804004153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865804004153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T08:38:57Z","timestamp":1705307937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865804004153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1590865804004153"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2004.05.015","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}